BP
Bionyra Pharma
France · Biotech · Healthtech · Enterprise software
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $165M | Apollo Health Ventures — Role not disclosedArkin Bio Capital — Role not disclosedJeito Capital — Role not disclosedSanofi Ventures — Role not disclosedSixty Degree Capital — Role not disclosedSofinnova Partners — Role not disclosedVives Partners — Role not disclosed |